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Summary
Lactating Holstein cows in one herd were milked three times daily and enrolled in a 2 
× 2 × 2 factorial design with eight treatments before first postpartum artificial insemi-
nation (AI). These treatments were employed to test ovulatory, progesterone, and 
luteolytic outcomes to three main effects: (1) two GnRH-PGF2α presynchronization 
programs (PG-3-G vs. Double Ovsynch); (2) 5- vs. 7-day Ovsynch-duration programs; 
and (3) two doses (25 mg on consecutive days) or one dose (50 mg) of PGF2α admin-
istered before timed AI. Results from this experiment demonstrate no differences in 
the presynchronization treatments of PG-3-G vs. Double Ovsynch; both are effective 
in initiating estrous cycles during warm-hot vs. cool-cold seasons. Although ovulatory 
responses were similar after the first GnRH administration, Double Ovsynch cows 
tended to have greater ovulation responses after the second GnRH administration. 
The single large, one-time administered 50-mg dose was effective in causing luteolysis 
in the 7-day program but slightly less effective in the 5-day program. Thus, when using 
the shorter 5-day program, the two 25-mg PGF2α doses administered 24 hours apart are 
recommended. Insufficient numbers of cows were treated to make conclusions about 
pregnancy outcomes in this one-herd study. Pregnancy rates, however, were reduced in 
5-day Ovsynch program when the single large 50-mg dose of PGF2α was employed.
Introduction
Potential limitations to a successful timed artificial insemination (AI) program for cows 
submitted for first service include cows that are not cycling (anovulatory), synchroniza-
tion of the ovulatory follicle that should ovulate just after the timed AI, and regression 
of the corpus luteum or corpora lutea (if more than one exists when PGF2α is adminis-
tered).
Two Ovsynch programs are used in the industry: 1) 5-day program: GnRH (G-1) — 
5 days — PGF2α — 24 hours — PGF2α — 48 hours — GnRH (G-2) + timed AI; or 
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2) 7-day program: GnRH (G-1) — 7 days — PGF2α — 56 hours — GnRH (G-2) — 
16 hours — timed AI.
Presynchronization programs before first postpartum AI used in the industry include 
combinations of PGF2α and GnRH (i.e., GnRH-PGF2α presynchronization options). 
These programs include: PG-3-G (PGF2α — 3 days — GnRH — 7 days — Ovsynch); 
G-6-G (PGF2α — 2 days — GnRH — 6 days — Ovsynch); or Double Ovsynch 
(GnRH — 7 days — PGF2α — 3 days — GnRH — 7 days — Ovsynch). These 
GnRH-PGF2α presynchronization programs are alternatives to the traditional PGF2α-
presynchronization programs (2 injections of PGF2α 14 days apart ¾ 10, 11, 12, or 14 
days — Ovsynch) because they often further improve pregnancy rates.
The advantages of these GnRH-PGF2α presynchronization programs include inducing 
ovulation in anovulatory cows, decreasing the percentage of cows with lower circulating 
progesterone concentrations (< 0.50 ng/mL) at G-1, increasing the percentage of cows 
with medium progesterone concentrations (0.50 < progesterone ≤ 3.0 ng/mL) at G-1, 
and increasing the proportion of cows with a corpus luteum (CL) at G-1. In addition, 
these GnRH-PGF2α presynchronization programs increase the percentage of cows with 
high progesterone (> 3.0 ng/mL) at the PGF2α treatment that immediately precedes 
timed AI and tend to increase average circulating progesterone at PGF2α.
Early studies in beef and dairy cows indicated that an improvement in pregnancy 
outcome seemed to occur when a shorter 5-day Ovsynch program was compared with 
a 7-day program. The problem with these published studies was the confounding of 
program duration (5 vs. 7 days) and use of one vs. two doses of PGF2α (6 to 24 h apart) 
to induce luteolysis. In none of the experiments were the two doses of PGF2α tested in 
both the 5- and 7-day programs. Therefore, a test of the two doses of PGF2α must occur 
in both programs to interpret the data correctly. If the 5-day program is not superior in 
pregnancy outcome, then the difference may simply be the result of improved complete 
luteolysis in cows treated with two doses of PGF2α, regardless of program duration.
Applying a second standard dose or a single larger dose of PGF2α seems to maximize 
complete luteolysis before timed AI. Corpora lutea less than 10 days old are resistant 
to complete regression after a single standard dose of PGF2α. Administering PGF2α as 
a single large dose on day 7 or as two standard doses on days 5 and 6 after G-1 (5-day 
Ovsynch) usually results in 70 to 84% of cows with progesterone < 0.3 ng/mL on the 
day of the timed AI. Progesterone concentrations at or near baseline at the final GnRH 
treatment influence the characteristics of GnRH-induced LH release and subsequent 
pregnancy risk. Increased dose or frequency of PGF2α at the end of Ovsynch program 
has enhanced luteolysis, reduced progesterone concentrations at timed AI, and in some 
cases slightly increased pregnancy risk compared with a standard single dose. Recent 
studies demonstrated increased complete luteolysis when 7-day Ovsynch programs 
included a second standard dose of PGF2α compared with a single standard dose.
Therefore, we proposed to address three questions. (1) Does the additional preGnRH 
(PreG; Figure 1) injection of Double Ovsynch improve synchronization characteris-
tics compared with the PG-3-G presynch program? (2) Will one large dose (50 mg) 
of PGF2α produce complete luteolysis similar to two standard 25-mg doses given 24 h 
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apart? (3) Is the 5-day Ovsynch program superior to the 7-day program when similar 
dose and frequency of PGF2α injections are administered in both programs?
Experimental Procedures
We enrolled 407 lactating dairy cows in a 2 × 2 × 2 factorial design consisting of 
8 treatments for 20 months (September 2015 through April 2017). This approach was 
employed to test ovulatory, progesterone, and luteolytic outcomes to three main effects 
(Figure 1): (1) two GnRH-PGF2α presynchronization programs (PG-3-G vs. Double 
Ovsynch); (2) 5- vs. 7-day Ovsynch-duration programs; and (3) two doses (25 mg 
on consecutive days) or one dose (50 mg) of PGF2α administered before timed AI 
(Figure 1). Double Ovsynch includes the additional PreGnRH injection (PreG; high-
lighted box in Figure 1) that is not part of the PG-3-G presynch program.
Blood samples were collected before G-1, before PGF2α, and at 24, 48, and 72 h after 
PGF2α (first or only PGF2α injection) to determine concentration ranges of progesterone 
and assess complete luteolysis (progesterone < 0.5 ng/mL at 48 to 72 h after the first or 
only dose of PGF2α). Transrectal ovarian scans by ultrasonography were used to assess 
ovulation after G-1 and G-2. Although pregnancy risk was assessed, this experiment was 
not designed to test pregnancy risk but focused on: (1) ovulation responses to G-1 and 
G-2; and (2) proportion of cows with complete luteolysis, as illustrated in Figure 1.
Results and Discussion
Ovarian Cyclicity
On the basis of progesterone concentrations, the proportion of cows that had initiated 
estrous cycles at the start of the Ovsynch program did not differ between PG-3-G and 
Double Ovsynch (Table 1). More cows tended (P = 0.09) to return to having estrous 
cycles before the onset of ovulation synchronization programs during the cool-cold 
season compared with the warm-hot season (88.4 vs. 81.9%).
Ovulation Response to GnRH-1
Neither single nor multiple ovulation responses to G-1 differed between PG-3-G and 
Double Ovsynch treatments (Table 1). Season had differing effects on multiple ovula-
tion in cows treated with PG-3-G and Double Ovsynch. During the warm-hot season, 
multiple ovulation occurred more frequently in PG-3-G than Double Ovsynch cows 
(17.4 vs. 6.4%), whereas during the cool-cold season, the reverse was detected (8.6 vs. 
13.6%, respectively).
Luteolysis
Decreasing concentrations of progesterone (luteolysis or regression of the corpus 
luteum or corpora lutea) after the PGF2α treatments just preceding timed AI are 
summarized in Table 2. At 24 hours after the first or only PGF2α dose, the proportion 
of cows with progesterone concentration < 1 ng/mL was greater (P < 0.05) in Double 
Ovsynch than PG-3-G treatments; greater (P < 0.05) in 7- vs. 5-day Ovsynch cows, 
and greater in cows treated with the 1 × 50 mg than 2 × 25 mg PGF2α dose (no inter-
actions). At 48 and 72 hours, more (P < 0.01) cows had progesterone < 1 ng/mL in 
the 7- vs. 5-day Ovsynch cows. At 72 hours, more (P < 0.01) cows had progesterone 
< 0.5 ng/mL in the 7- vs. 5-day Ovsynch cows and more (P < 0.01) cows receiving 
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the 2 × 25 mg dose than the 1 × 50 mg dose. An interaction, however, was detected 
at 48 and 72 hours between the Ovsynch duration and the PGF2α dose-frequency 
(Figure 2). Although mean progesterone was < 0.05 ng/mL at both time points, the 
single 1 × 50 mg was slightly less effective than the 2 × 25 mg dose in reducing concen-
trations of progesterone in the 5- vs. 7-day Ovsynch-treated cows. Thus, the single large 
dose was equally effective as the 2 × 25-mg dose in the 7-day Ovsynch program, but less 
so when applied to cows in the shorter 5-day program.
Ovulation Response to GnRH-2
Single ovulation after G-2 differed slightly between presynch treatments (Table 3). 
Cows presynched with Double Ovsynch tended (P = 0.085) to have greater ovula-
tory responses than PG-3-G cows. Duration of Ovsynch (5 vs. 7 days) had no effect 
on ovulation response to G-2. Single ovulatory response to G-2 tended (P = 0.073) to 
be greater during the cooler-cold season than during the warmer-hot season (94.2 vs. 
88.3%, respectively).
In contrast, multiple ovulation tended (P = 0.108) to be greater in PG-3-G than 
Double Ovsynch cows and greater (P = 0.004) in 5- vs. 7-day cows. An interaction 
(P = 0.011), however, was detected between presynchronization treatments and 
Ovsynch duration (Table 3). Multiple ovulation was greater in PG-3-G cows in the 
5-day compared with the 7-day program, whereas no differences in multiple ovulation 
occurred between program durations in Double Ovsynch cows. Season had no effect on 
the frequency of multiple ovulation.
Pregnancy Outcomes
No overall differences were detected in pregnancy rate between PG-3-G and Double 
Ovsynch treatments (Table 3) or between the 5- vs. 7-day program, although numeri-
cally pregnancy rates were greater for PG-3-G and 7-day program cows. Because of 
the differences in the effectiveness of luteolysis (decreasing progesterone after PGF2α 
during the timed AI week), an interaction between Ovsynch duration and PGF2α 
dose-frequency was detected (Table 3). Cows receiving the 1 × 50 mg dose in the 7-day 
program had greater (P < 0.05) pregnancy rates than cows receiving the 1 × 50 mg dose 
in the 5-day program.
Results from this experiment demonstrate no significant differences in the presynchro-
nization responses to PG-3-G vs. Double Ovsynch treatments. Both are effective in 
initiating estrous cycles during all seasons. Although ovulatory responses were similar 
after G-1, Double Ovsynch cows tended to have greater ovulation responses after G-2. 
The single large, one-time administered 50-mg dose was effective in causing luteolysis 
in the 7-day but less so in the 5-day cows. Thus, when using the shorter 5-day program, 
the two 25-mg doses administered 24 hours apart are recommended. Insufficient 
numbers of cows were treated to make conclusions about pregnancy outcomes in this 
one-herd study. Pregnancy rates, however, were reduced in 5-day compared with the 
7-day Ovsynch program when the single large 50-mg dose of PGF2α was employed. 
As expected, pregnancy rate was greater (P = 0.056) during the cooler-cold months 
compared with warmer-hot season (40.2 vs. 30.0%).
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Table 1. Ovarian cyclicity assessed at 7 days after two presynchronization treatments and 
ovulatory responses response to GnRH-1 (G-1)
Presynchronization1
Item DO PG-3-G P-value
Cyclicity before G-1, % 88.8 90.5 0.566
Single ovulation to G-1, % 68.4 63.2 0.267
Multiple ovulation to G-1, % 7.8 8.4 0.845
1Double Ovsynch (DO) = GnRH — 7 days — PGF2α — 3 days — GnRH; PG-3-G = PGF2α — 3 days — GnRH.
Table 2. Percentage of cows with progesterone concentrations < 1 ng/mL at 24, 48, and 72 hours after the 
first or only dose of PGF2α or < 0.5 ng/mL at 72 hours
Hours after the first or 
only PGF2α treatment










2 × 25 
(n = 164)
1 × 50 
(n = 163)
24 (< 1 ng/mL) 57.3a 36.0b 46.0a 57.3b 40.5c 62.8d
485 (< 1 ng/mL) 88.4a 90.2a 84.0c 95.5d 92.0a 86.6a
725 (< 1 ng/mL) 95.7a 94.5a 90.8c 99.4d 98.2a 92.7b
725 (< 0.5 ng/mL) 95.9a 94.1a 90.6c 99.4d 98.2a 92.0b
a-bMeans differ (P < 0.05) within main effect category.
c-d Means differ (P < 0.01) within main effect category.
1Double Ovsynch (DO) = (DO) = GnRH — 7 days — PGF2α — 3 days — GnRH; 
2PG-3-G = PGF2α — 3 days — GnRH.
3Five = GnRH — 5 days — PGF2α; Seven = GnRH — 7 days — PGF2α; both were initiated 7 d after the end of the presynchronization  
treatments.
4Two, 25-mg doses 24 h apart or one, 50-mg dose.
5Interaction (P < 0.05) between Ovsynch duration and PGF2α dose.
Table 3. Ovulatory responses to GnRH-2 (G-2) in response to the presynchronization (Pre; PG-3-G or 
Double Ovsynch) and 5- or 7-day Ovsynch (Ovs) programs
DO1 PG-3-G2 P-value
Item Five3 Seven3 Five3 Seven3 Pre Ovs Pre × Ovs
Single ovulation, % 96.0 95.4 90.6 93.0 0.085 0.822 0.569
Multiple ovulation, % 16.0 14.7 32.4 11.0 0.108 0.004 0.011
1Double Ovsynch (DO) = (DO) = GnRH — 7 days — PGF2α — 3 days ¾ GnRH; 
2PG-3-G = PGF2α — 3 days — GnRH.
3Five = GnRH — 5 days — PGF2α; Seven = GnRH — 7 days — PGF2α; both were initiated 7 d after the end of the presynchronization  
treatments.
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Table 4. Pregnancy rate for lactating cows treated with two presynchronization treat-
ments (Double Ovsynch [DO] vs. PG-3-G), two Ovsynch durations (5- vs. 7-days), and 
two PGF2α (2 × 25-mg vs. 1 × 50-mg doses)
Presynch1
5 day2 7 day2 DO vs. 
PG-3-G2 × 25 mg3 1 × 50 mg3 2 × 25 mg3 1 × 50 mg3
DO 34.5 (55) 35.1 (57) 27.8 (54) 36.8 (57) 33.6 (223)
PG-3-G 40.3 (57) 24.1 (54) 40.7 (59) 49.1 (57) 38.8 (227)
Total4 37.5ab (112) 29.7a (111) 34.5ab (113) 43.0b (114)
5- vs. 7-day 33.6 (223) 38.8 (227)
a-b Mean percentages with different superscript letters differ (P < 0.05).
1DO = GnRH — 7 days — PGF2α — 3 days — GnRH; PG-3-G = PGF2α — 3 days — GnRH;  
PG-3-G = PGF2α — 3 days — GnRH. 
2Five = GnRH — 5 days — PGF2α; Seven = GnRH — 7 days — PGF2α; both were initiated 7 d after the end  
of the presynchronization treatments.
3Treatment with PGF2α (2 × 25-mg vs. 1 × 50-mg doses).
4Interaction of Ovsynch duration vs. PGF2α dose (P = 0.043).
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Figure 1. Illustration of the 2 × 2 × 2 factorial design of 8 treatments. Main effects 
included presynchronization (Double Ovsynch vs. PG-3-G), Ovsynch duration  
(5 vs. 7 d), and PGF2α dose-frequency (2 × 25 vs. 1 × 50-mg doses) and schedule for blood 
collection and transrectal ultrasonograms. B = blood sample, S = transrectal ultrasono-
gram of ovaries; PrePG or PG = 25 mg PGF2α, 2PG = 50 mg PGF2α, PreG, G-1 or  
G-2 = 100 μg gonadotropin-releasing hormone (GnRH), PD = pregnancy diagnosis.
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Figure 2. Progesterone concentrations at 48 (A) and 72 (B) hours after the first or only 
injection of PGF2α showing the lesser effectiveness of the 1 × 50 mg dose to reduce proges-
terone concentrations in the 5-day but not the 7-day Ovsynch program.
